SAT0728-HPR A patient satisfaction survey: patients' perceptions of biologic dose tapering
SAT0728-HPR A patient satisfaction survey: patients' perceptions of biologic dose tapering
<h3>Background</h3> Evidence shows that remission can be maintained in selected patients whose biologic medication is dose tapered<sup>1</sup>. In June 2015 we began tapering the doses of selected rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis patients in disease remission. The process was agreed with the local commissioners and a protocol<sup>2</sup> was …